Publicaties
Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still's disease Vrije Universiteit Brussel
Macrophage activation syndrome (MAS) is a severe, potentially fatal complication of rheumatic diseases. This case demonstrates the significant challenges and therapeutic considerations in adult-onset Still's disease (AOSD) complicated with MAS at initial presentation, which will be discussed. MAS in our patient was refractory to the first-line therapy with high-dose corticosteroids, early administration of anakinra at a standard dosage and ...
Fulminant macrophage activation syndrome in a patient with anti-synthetase syndrome Vrije Universiteit Brussel KU Leuven
GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery Universiteit Gent Vlaams Instituut voor Biotechnologie
Regulation of macrophage motility by the water channel aquaporin-1 : crucial role of M0/M2 phenotype switch Universiteit Gent
Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer Universiteit Gent
In vivo inhibition of c-MYC in myeloid cells impairs tumor-associated macrophage maturation and pro-tumoral activities. Vrije Universiteit Brussel
The immunophenotype of osteoclasts and macrophage polykaryons Vrije Universiteit Brussel
AIM: Osteoclasts are multinucleated cells which are specialised to carry out lacunar bone resorption. Osteoclasts form part of the mononuclear phagocyte system, and immunophenotypic criteria for distinction from macrophage polykaryons include expression of CD51 (vitronectin receptor) and absence of HLA-DR and CD14.
METHODS: The expression of CD14, CD163, HLA-DR and CD51 in formalin-fixed paraffin-embedded sections of normal bone and ...